Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of ISIS 546254 for Preventive Treatment of Chronic Migraine

Next Previous
Trial Profile

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of ISIS 546254 for Preventive Treatment of Chronic Migraine

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 11 Sep 2018

At a glance

  • Drugs IONIS PKKRx (Primary)
  • Indications Migraine
  • Focus Adverse reactions; Therapeutic Use

    • Most Recent Events

    • 04 Sep 2018 Status changed from recruiting to active, no longer recruiting.
    • 16 Apr 2018 Planned End Date changed from 31 Dec 2017 to 31 Dec 2018.
    • 16 Apr 2018 Planned primary completion date changed from 31 Dec 2017 to 31 Dec 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top